Author Contributions Concept and design: Ibaadat Kahlon, Simone Sekhon , William Latson Acquisition, analysis, or interpretation of data: Ibaadat Kahlon, William Latson Drafting of the manuscript: Ibaadat Kahlon, Simone Sekhon , William Latson Critical review of the manuscript for important intellectual content: Ibaadat Kahlon, Simone Sekhon , William Latson Supervision: William Latson References 1.A new drug for obesity: tirzepatide
While some fatigue is common during early weight loss, progressive weakness, particularly if accompanied by muscle pain or cramping, may suggest inadequate protein intake, electrolyte imbalances, or other metabolic concerns that require evaluation
While not a formal medical diagnosis, this concept has gained attention with the rise of GLP-1 medications for diabetes and weight management
This modification is what gives tirzepatide its long half-life by allowing it to bind to albumin in the bloodstream
Improved Energy: Vitamin B12 can improve or boost energy levels
PlexusDx's Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes that influence how your body responds to each medication class